{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:20:42Z","timestamp":1790803242585,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.gore.2021.100757","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T14:25:40Z","timestamp":1617200740000},"page":"100757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pelvic exenteration for recurrent or advanced gynecologic malignancies \u2013 Analysis of outcome and complications"],"prefix":"10.1016","volume":"36","author":[{"given":"L.","family":"ter Glane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boekhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2021.100757_b0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2012.07.002","article-title":"Prognostic factors in pelvic exenteration for gynecological malignancies","volume":"38","author":"Baiocchi","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2011.03.003","article-title":"Pelvic exenteration in gynecologic oncology: A single institution study over 20 years","volume":"122","author":"Benn","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2005.05.034","article-title":"Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA","volume":"99","author":"Berek","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00000658-196004000-00018","article-title":"Pelvic exenteration operations: with summary of sixty-six cases surviving more than five years","volume":"151","author":"Brunchschwig","year":"1960","journal-title":"Ann. Surg."},{"key":"10.1016\/j.gore.2021.100757_b0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","article-title":"Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy","volume":"1","author":"Brunschwig","year":"1948","journal-title":"Cancer"},{"key":"10.1016\/j.gore.2021.100757_b0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/IGC.0000000000000011","article-title":"Morbidity after pelvic exenteration for gynecological malignancies : A retrospective multicentric study of 230 patients","volume":"24","author":"Chiantera","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2021.100757_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00404-019-05154-4","article-title":"Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases","volume":"300","author":"de Gregorio","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.gore.2021.100757_b0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/IGC.0000000000000612","article-title":"Quality of life in women after pelvic exenteration for gynecological malignancies: A multicentric study","volume":"28","author":"Dessole","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2021.100757_b0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.gore.2021.100757_b0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.20686","article-title":"Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers","volume":"95","author":"Fleisch","year":"2007","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jso.21518","article-title":"Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies","volume":"101","author":"Fotopoulou","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2005.10.011","article-title":"Total pelvic exenteration: The Albert Einstein College of Medicine\/Montefiore Medical Center Experience (1987 to 2003)","volume":"101","author":"Goldberg","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00404-010-1544-8","article-title":"Palliative pelvic exenteration for patients with gynecological malignancies","volume":"283","author":"Guimar\u00e3es","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.gore.2021.100757_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(06)70903-2","article-title":"Pelvic exenteration for gynaecological tumours: achievements and unanswered questions","author":"H\u00f6ckel","year":"2006","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.gore.2021.100757_b0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/IGC.0b013e318287a874","article-title":"Pelvic exenteration for recurrent gynecologic malignancy: A study of 28 consecutive patients at a single institution","volume":"23","author":"J\u00e4ger","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2021.100757_b0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IGC.0b013e31824eb8cd","article-title":"Pelvic exenterations for gynecological malignancies: A study of 36 cases","volume":"22","author":"Kaur","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2021.100757_b0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2013.02.038","article-title":"Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience","volume":"130","author":"Landoni","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2009.03.029","article-title":"Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan","volume":"114","author":"Maggioni","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0095","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/IGC.0b013e3181a8351e","article-title":"Exenterations 60 Years after first description; Results of a survey among US and German gynecologic oncology centers","volume":"19","author":"Marnitz","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2021.100757_b0100","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1245\/ASO.2003.06.011","article-title":"A prospective evaluation of palliative outcomes for surgery of advanced malignancies","volume":"10","author":"McCahill","year":"2003","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2010.11.044","article-title":"Pelvic exenteration in the age of modern chemoradiation","volume":"121","author":"McLean","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0110","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/pon.4832","article-title":"Quality of life after pelvic exenteration for gynecologic cancer: Findings from a qualitative study","volume":"27","author":"Nelson","year":"2018","journal-title":"Psychooncology."},{"key":"10.1016\/j.gore.2021.100757_b0115","doi-asserted-by":"crossref","unstructured":"PelvExCollaborative, 2019. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy. Ann. Surg. 270, 899\u2013905. https:\/\/doi.org\/10.1097\/sla.0000000000003533.","DOI":"10.1097\/SLA.0000000000003533"},{"key":"10.1016\/j.gore.2021.100757_b0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0090-8258(87)90029-1","article-title":"Pelvic exenteration: Prognostic significance of regional lymph node metastasis","volume":"26","author":"Rutledge","year":"1987","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","article-title":"Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer","volume":"125","author":"Schmidt","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2016.10.018","article-title":"Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study","volume":"143","author":"Seagle","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0135","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00006250-198906000-00024","article-title":"Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix","volume":"73","author":"Shingleton","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gore.2021.100757_b0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9378(85)80167-8","article-title":"Palliative exenteration\u2014What, when, and why?","volume":"152","author":"Stanhope","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gore.2021.100757_b0145","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0002-9378(75)90908-4","article-title":"Exenterative operations: experience with 198 patients","volume":"121","author":"Symmonds","year":"1975","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gore.2021.100757_b0150","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygyno.2013.02.024","article-title":"Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies","volume":"129","author":"Urh","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100757_b0155","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.06.034","article-title":"Overall survival after pelvic exenteration for gynecologic malignancy","volume":"134","author":"Westin","year":"2014","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892100062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892100062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:56:30Z","timestamp":1762480590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235257892100062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":31,"alternative-id":["S235257892100062X"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2021.100757","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pelvic exenteration for recurrent or advanced gynecologic malignancies \u2013 Analysis of outcome and complications","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2021.100757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100757"}}